Trademark: 88701131
Status Date
Monday, February 5, 2024
Filing Date
Thursday, November 21, 2019
Published for Opposition
Tuesday, August 18, 2020
5 pharmaceutical preparations for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders but excluding DNA-based gene therapy; therapeutic products for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy
1 biological and chemical agents for scientific and research use
Feb 7, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 5, 2024
Sou Extension 3 Granted
Feb 5, 2024
Sou Extension 3 Filed
Feb 5, 2024
Sou Teas Extension Received
Jul 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 20, 2023
Sou Extension 2 Granted
Jul 20, 2023
Sou Extension 2 Filed
Jul 20, 2023
Sou Teas Extension Received
Jan 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 20, 2023
Sou Extension 1 Granted
Jan 20, 2023
Sou Extension 1 Filed
Jan 20, 2023
Sou Teas Extension Received
Nov 22, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 22, 2022
Teas Change Of Correspondence Received
Nov 22, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 22, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 22, 2022
Teas Change Of Owner Address Received
Aug 9, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 29, 2022
Ttab Release Case To Trademarks
Jun 29, 2022
Opposition Terminated No. 999999
Jun 29, 2022
Opposition Dismissed No. 999999
Oct 28, 2020
Opposition Instituted No. 999999
Oct 22, 2020
Changes/Corrections After Pub Approval Entered
Oct 16, 2020
Assigned To Petition Staff
Sep 16, 2020
Extension Of Time To Oppose Received
Sep 2, 2020
Teas Post Publication Amendment Received
Aug 18, 2020
Official Gazette Publication Confirmation E-Mailed
Aug 18, 2020
Published For Opposition
Jul 29, 2020
Notification Of Notice Of Publication E-Mailed
Jul 10, 2020
Approved For Pub - Principal Register
Jun 26, 2020
Teas/Email Correspondence Entered
Jun 26, 2020
Correspondence Received In Law Office
Jun 26, 2020
Teas Response To Office Action Received
Apr 29, 2020
Automatic Update Of Assignment Of Ownership
Feb 12, 2020
Automatic Update Of Assignment Of Ownership
Dec 28, 2019
Notification Of Non-Final Action E-Mailed
Dec 28, 2019
Non-Final Action E-Mailed
Dec 28, 2019
Non-Final Action Written
Dec 27, 2019
Assigned To Examiner
Nov 27, 2019
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24
